Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Metastatic Pancreatic Ductal Adenocarcinoma × IFL protocol × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 13 Neoplasm Metastasis 5 Colonic Neoplasms 2 Sarcoma 1 Rectal Neoplasms 1 Neoplasms 1 Metastatic Pancreatic Ductal Adenocarcinoma 1 Lymphoma, Non-Hodgkin 1 Leukemia, Myeloid, Acute 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Chondrosarcoma 1 Carcinoma, Non-Small-Cell Lung 1 Advanced Solid Tumor 1

Interventions

SLC-0111 1 IFL protocol 1 Gemcitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03331640 2022-01-11

PANTHEON

AIO-Studien-gGmbH

Phase 2 Terminated

Gastrointestinal

Metastatic Pancreatic Ductal Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡